Excerpts from the United States Renal Data System, 2008 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States, National Institutes of Health NIDDK/DKUHD

被引:151
|
作者
Collins, Allan J.
Foley, Robert N.
Herzog, Charles
Chavers, Blanche
Gilbertson, David
Ishani, Areef
Kasiske, Bertram
Liu, Jiannong
Mau, Lih-Wen
McBean, Marshall
Murray, Anne
Peter, Wendy St.
Guo, Haifeng
Li, Qi
Li, Shuling
Li, Suying
Peng, Yi
Qiu, Yang
Roberts, Tricia
Skeans, Melissa
Snyder, Jon
Solid, Craig
Wang, Changchun
Weinhandl, Eric
Zaun, David
Arko, Cheryl
Chen, Shu-Cheng
Dalleska, Frederick
Daniels, Frank
Dunning, Stephan
Ebben, James
Frazier, Eric
Hanzlik, Christopher
Johnson, Roger
Sheets, Daniel
Wang, Xinyue
Forrest, Beth
Constantini, Edward
Everson, Susan
Eggers, Paul
Agodoa, Lawrence
机构
基金
美国国家卫生研究院;
关键词
D O I
10.1053/j.ajkd.2008.10.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This 20th Annual Data Report reports data through 2006. This year we present a new volume on chronic kidney disease (CKD) in the United States, estimating the population using National Health and Nutrition Examination Surveys. We also use diagnostic codes and laboratory data to estimate the population within employer group health plans, assess use of the new International Classification of Diseases, Ninth Revision, Clinical Modification CKD diagnosis codes, and report on morbidity, mortality, care during the transition to end-stage renal disease, and expenditures in patients with CKD. In 2006, a total of 110,854 patients started end-stage renal disease therapy, with the prevalent population reaching 506,256; a total of 18,052 transplantations were performed; and 151,502 patients had functioning grafts at year end. Program expenditures reached $33.5 billion, with $22.7 billion from Medicare accounting for 6.4% of total Medicare expenditures. The incident rate increased 3.4% to 360 per million-the highest in 5 years. Treatment targets are now reached by 93% of hemodialysis patients. Fistula use is 45.4% in prevalent patients, with attempted placements doubling since 1996. Catheter use continues to be a concern. Hemoglobin levels greater than 12 g/dL are common, particularly in some providers. First year mortality rates for incident hemodialysis patients have decreased for the first time in 11 years; however, pediatric patient survival has not improved. The rate of infectious hospitalizations in the first year of dialysis therapy now equals that of cardiovascular hospitalizations. The public health impact of kidney disease is larger than previously appreciated, and early detection, education, intervention, and risk-factor control are needed to address the heavy burden of cardiovascular disease and adverse events in this vulnerable population.
引用
收藏
页码:S1 / S374
页数:374
相关论文
共 50 条
  • [31] Causes of Death in End-Stage Kidney Disease: Comparison between the United States Renal Data System and a Large Integrated Health Care System
    Bhandari, Simran K.
    Zhou, Hui
    Shaw, Sally F.
    Shi, Jiaxiao
    Tilluckdharry, Natasha S.
    Rhee, Connie M.
    Jacobsen, Steven J.
    Sim, John J.
    AMERICAN JOURNAL OF NEPHROLOGY, 2022, 53 (01) : 32 - 40
  • [32] Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States
    Hsu, CY
    Lin, F
    Vittinghoff, E
    Shlipak, MG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (11): : 2902 - 2907
  • [33] Suicide in the United States end-stage renal disease program
    Kurella, M
    Kimmel, PL
    Young, BS
    Chertow, GM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (03): : 774 - 781
  • [34] The direction of end-stage renal disease reimbursement in the United States
    Lockridge, RS
    SEMINARS IN DIALYSIS, 2004, 17 (02) : 125 - 130
  • [35] Adequacy of treatment for end-stage renal disease in the United States
    Lundin, AP
    Port, FK
    ADVANCES IN INTERNAL MEDICINE, VOL 41, 1996, 41 : 323 - 363
  • [36] The continuum of chronic kidney disease and end-stage renal disease: Challenges and opportunities for chronic peritoneal dialysis in the United States
    Mehrotra, Rajnish
    PERITONEAL DIALYSIS INTERNATIONAL, 2007, 27 (02): : 125 - 130
  • [37] Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival
    Abbott, KC
    Agodoa, LY
    CLINICAL NEPHROLOGY, 2002, 57 (03) : 208 - 214
  • [38] United States Renal Data System 2009 Annual Data Report
    Collins, Allan J.
    Foley, Robert N.
    Herzog, Charles
    Chavers, Blanche M.
    Gilbertson, David
    Ishani, Areef
    Kasiske, Bertram L.
    Liu, Jiannong
    Mau, Lih-Wen
    McBean, Marshall
    Murray, Anne
    St Peter, Wendy
    Guo, Haifeng
    Li, Shuling
    Li, Suying
    Peng, Yi
    Qiu, Yang
    Roberts, Tricia
    Skeans, Melissa
    Snyder, Jon
    Solid, Craig
    Wang, Changchun
    Weinhandl, Eric
    Zaun, David
    Arko, Cheryl
    Chen, Shu-Cheng
    Dalleska, Frederick
    Daniels, Frank
    Dunning, Stephan
    Ebben, James
    Frazier, Eric
    Hanzlik, Christopher
    Johnson, Roger
    Sheets, Daniel
    Wang, Xinyue
    Forrest, Beth
    Constantini, Edward
    Everson, Susan
    Eggers, Paul W.
    Agodoa, Lawrence
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (01) : VI - +
  • [39] Diabetes in chronic kidney disease and end-stage renal disease: Highlights from the USRDS 2005 Annual Data Report
    Gladstone, Elisa H.
    DIABETES, 2006, 55 : A179 - A179
  • [40] Discrepancy in the epidemiology of nondiabetic chronic renal insufficiency and end-stage renal disease in black and white Americans: The third National Health and Nutrition Examination Survey and United States Renal Data System
    Trivedi, HS
    Pang, MMH
    AMERICAN JOURNAL OF NEPHROLOGY, 2003, 23 (06) : 448 - 457